The DEA allowed hundreds of thousands of fentanyl pills to circulate in New Mexico from 2023 to 2025 as a strategic method to build major federal drug cases.Whistleblowers have criticized the tactic for endangering public safety, drawing direct comparisons to past government scandals involving illicit goods.A
DOJ investigation cleared the agency of wrongdoing, though concerns persist regarding the impact on regional overdose rates.